{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 34, "transaction_limit": 160, "filters": {"q": "", "ticker": "IONS", "sector": "", "industry": "", "side": "", "start": "2026-06-30", "end": "2026-08-14"}, "summary": {"total": 34, "acquisition_count": 23, "disposal_count": 11, "acquisition_value": 1995058.13, "acquisition_value_label": "$2.0M", "disposal_value": 3549193.5342, "disposal_value_label": "$3.5M", "net_value": -1554135.4042, "net_value_label": "$-1.6M", "flow_tone": "negative", "largest_value_label": "$1.3M", "top_sector": "Healthcare", "window_label": "30 Jun 2026 to 14 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 34, "value": "5544251.6642", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$5.5M"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 15, "disposals": 3, "total": 18, "bar_width": 100.0}, {"transaction_date": "2026-07-07", "acquisitions": 2, "disposals": 6, "total": 8, "bar_width": 44.4}, {"transaction_date": "2026-07-15", "acquisitions": 4, "disposals": 2, "total": 6, "bar_width": 33.3}, {"transaction_date": "2026-07-30", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 5.6}, {"transaction_date": "2026-07-31", "acquisitions": 1, "disposals": 0, "total": 1, "bar_width": 5.6}], "side_mix": {"acquisitions": 23, "disposals": 11, "acquisition_share": 67.6, "disposal_share": 32.4}}, "company_flows": [{"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-31", "acquisitions": 4, "disposals": 6, "acquired_value": 1995058.13, "acquired_value_label": "$2.0M", "disposed_value": 3549193.5342, "disposed_value_label": "$3.5M", "net_value": -1554135.4042, "net_value_label": "$-1.6M", "acquisition_share": 40.0, "disposal_share": 60.0, "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}], "company_overview": [{"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-31", "filings": 34, "acquisitions": 23, "disposals": 11, "acquired_value": 1995058.13, "acquired_value_label": "$2.0M", "disposed_value": 3549193.5342, "disposed_value_label": "$3.5M", "net_value": -1554135.4042, "net_value_label": "$-1.6M", "acquisition_share": 67.6, "disposal_share": 32.4, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}], "transactions": [{"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-31", "executive": "HAYDEN, MICHAEL R", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5000.0, "share_price": 51.6, "transaction_value": 258000.0, "transaction_value_label": "$258.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T04:23:02.529118+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-30", "executive": "HAYDEN, MICHAEL R", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 15000.0, "share_price": 53.38, "transaction_value": 800700.0, "transaction_value_label": "$800.7K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-13T04:23:02.531437+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BERTHELSEN, SPENCER R", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "D", "side": "Disposal", "shares": 5220.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.889124+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "BERTHELSEN, SPENCER R", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5220.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.886266+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "HANTSON, LUDWIG", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 3399.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.878797+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "HERMAN, JOAN E", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "D", "side": "Disposal", "shares": 5220.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.892430+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "HERMAN, JOAN E", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5220.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.890757+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "REIKES, PETER N", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 3399.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-08-04T22:08:36.894125+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "BENNETT, C FRANK", "executive_title": "EVP, Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 15000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context", "fetched_at": "2026-07-28T22:04:51.040116+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "BENNETT, C FRANK", "executive_title": "EVP, Chief Scientific Officer", "security_type": "Restricted Stock Unit", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-28T22:04:51.046474+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "DIAZ, ALLENE M.", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 10111.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-28T22:04:51.032814+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "BENNETT, C FRANK", "executive_title": "EVP, Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": 85.462, "transaction_value": 1281930.0, "transaction_value_label": "$1.3M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-28T22:04:51.044097+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "DIAZ, ALLENE M.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10111.0, "share_price": 85.4156, "transaction_value": 863637.1316, "transaction_value_label": "$863.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-28T22:04:51.037807+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "DIAZ, ALLENE M.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10111.0, "share_price": 47.11, "transaction_value": 476329.21, "transaction_value_label": "$476.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-28T22:04:51.030570+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "BENNETT, C FRANK", "executive_title": "EVP, Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5536.0, "share_price": 83.579, "transaction_value": 462693.344, "transaction_value_label": "$462.7K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-28T22:04:51.041946+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-07", "executive": "KORDASIEWICZ, HOLLY B.", "executive_title": "EVP, Chief Development Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 362.0, "share_price": 84.3, "transaction_value": 30516.6, "transaction_value_label": "$30.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-28T22:04:51.035339+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BERTHELSEN, SPENCER R", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.348450+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BERTHELSEN, SPENCER R", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.346967+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "DIAZ, ALLENE M.", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.345476+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "DIAZ, ALLENE M.", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.349985+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HAYDEN, MICHAEL R", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.368070+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HAYDEN, MICHAEL R", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.369485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HERMAN, JOAN E", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.356210+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "HERMAN, JOAN E", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.357555+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.366561+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 11518.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.363538+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.365102+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "LOSCALZO, JOSEPH", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.351507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "LOSCALZO, JOSEPH", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.354676+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "YANG, MICHAEL J.", "executive_title": "Director", "security_type": "Non-Qualified Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 5369.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.343996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "YANG, MICHAEL J.", "executive_title": "Director", "security_type": "Restricted Stock Unit", "side_code": "A", "side": "Acquisition", "shares": 2301.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "equity_award", "evidence_class_label": "Equity compensation", "evidence_quality": "Context", "fetched_at": "2026-07-21T22:00:11.353119+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11419.0, "share_price": 79.0394, "transaction_value": 902550.9086, "transaction_value_label": "$902.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-21T22:00:11.362009+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 11518.0, "share_price": 39.94, "transaction_value": 460028.92, "transaction_value_label": "$460.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-21T22:00:11.359078+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}, {"symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "KLEIN, JOSEPH III", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 99.0, "share_price": 79.45, "transaction_value": 7865.55, "transaction_value_label": "$7.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-21T22:00:11.360496+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ions/", "research_links": {"chart": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/", "report": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "factor": "/factors/ticker/5af1f9c4-6052-4fe7-80ab-024b91697514/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}